Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.0157M
March 31, 2026 -0.012M
December 31, 2025 -15.52M
September 30, 2025 -0.0061M
June 30, 2025 -0.0113M
March 31, 2025 -0.0136M
December 31, 2024 -0.0116M
September 30, 2024 -0.0137M
June 30, 2024 -0.012M
March 31, 2024 -0.0177M
December 31, 2023 -0.0184M
September 30, 2023 -0.0068M
June 30, 2023 -0.0142M
March 31, 2023 -0.0157M
December 31, 2022 -0.011M
September 30, 2022 -1.755M
June 30, 2022 0.0364M
March 31, 2022 -0.0413M
December 31, 2021 -2.848M
September 30, 2021 -0.0017M
June 30, 2021 -1.109M
March 31, 2021 -0.0238M
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. -0.912M
Lantheus Holdings, Inc. 92.20M
Zomedica Corp. -2.515M
IDEXX Laboratories, Inc. 347.16M
Neogen Corp. 30.20M

Cash from Operations (Quarterly) Related Metrics